Injectable Drug Delivery Devices

Injectable Drug Delivery Devices Comprehensive Study by Application (Auto-immune diseases, Hormonal Disorders, Orphan Diseases, Oncology, Others), Pattern (Curative Care, Immunization, Other Usage Pattern), Administration (Circulatory/Musculoskeletal, Organs, Central Nervous System), End Use (Hospitals, Specialty Clinics), Packaging (Ampules, Vials, Cartridges, Bottles) Players and Region - Global Market Outlook to 2032

Injectable Drug Delivery Devices Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Injectable Drug Delivery Devices
Whether it's biologics for parenteral administration, asthma medications that require an inhaler, or chemotherapeutic treatments administered intravenously, the majority of the world's best-selling medicines require a drug delivery device. The method or process of delivering a pharmaceutical substance to create a therapeutic effect in people or animals is known as drug delivery. Nasal and pulmonary medication administration are becoming increasingly important in the treatment of human illnesses. These methods, especially for peptide and protein therapies, offer potential alternatives to parenteral drug administration. Drug delivery business is focused on developing methods to improve the injection experience for patients, such as using helpful reminders, self-use devices, linking to smartphones, and making syringes larger or smaller, as well as making containers kinder and smarter.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Injectable Drug Delivery Devices market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Becton, Dickinson and Company (United States), Pfizer Inc. (United States), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (United States), Gerresheimer (Germany), Terumo Corporation (Japan), Ypsomed (Switzerland), Sandoz (Novartis AG) (Switzerland), B. Braun Melsungen (Germany) and Baxter International, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Sulzer Ltd (Switzerland), Schott AG (Germany) and SHL Medical (Switzerland).

Segmentation Overview
AMA Research has segmented the market of Global Injectable Drug Delivery Devices market by , Application (Auto-immune diseases, Hormonal Disorders, Orphan Diseases, Oncology and Others) and Region.



On the basis of geography, the market of Injectable Drug Delivery Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Pattern, the sub-segment i.e. Curative Care will boost the Injectable Drug Delivery Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Administration, the sub-segment i.e. Circulatory/Musculoskeletal will boost the Injectable Drug Delivery Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Use, the sub-segment i.e. Hospitals will boost the Injectable Drug Delivery Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Packaging, the sub-segment i.e. Ampules will boost the Injectable Drug Delivery Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technical Progress in Healthcare Industry

Market Growth Drivers:
Prevalence of Chronic Diseases and Demand for Self-Administered Injection Devices

Challenges:
Fierce Competitive Pressure and Regulatory Approval

Restraints:
Concerns Regarding Infections and Injuries and Defects and Product Recalls

Opportunities:
Growing Demand for Biosimilar and Generic Injectables

Market Leaders and their expansionary development strategies
On 24th August 2020 - Sulzer to Acquired Haselmeier (Leading Drug Delivery Device Developer and Manufacturer), Valued at EUR 100 million. Haselmeie's Novel Medication Delivery Devices, Such as Subcutaneous Self-Injection Pens, Will Be Included in The Deal for Use in Fast-Growing Healthcare Segments.
On 31st March 2020 – SHL Medical Acquired Weibel, the Acquisition is Aimed to Develop Novel Drug Delivery Systems with the Combination of Weibel’s R&D Expertise across Self-Administered Injectable Devices, Packaging Technologies and Delivery Systems Applied on Parenteral Drugs for Use at Home, At Point of Care, And at The Clinic.


Key Target Audience
Injectable Drug Delivery Devices Manufactures, New Entrants and Investors, Injectable Drug Delivery Devices Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Auto-immune diseases
  • Hormonal Disorders
  • Orphan Diseases
  • Oncology
  • Others
By Pattern
  • Curative Care
  • Immunization
  • Other Usage Pattern

By Administration
  • Circulatory/Musculoskeletal
  • Organs
  • Central Nervous System

By End Use
  • Hospitals
  • Specialty Clinics

By Packaging
  • Ampules
  • Vials
  • Cartridges
  • Bottles

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Chronic Diseases
      • 3.2.2. Demand for Self-Administered Injection Devices
    • 3.3. Market Challenges
      • 3.3.1. Fierce Competitive Pressure
      • 3.3.2. Regulatory Approval
    • 3.4. Market Trends
      • 3.4.1. Technical Progress in Healthcare Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Injectable Drug Delivery Devices, by Application, Pattern, Administration, End Use, Packaging and Region (value) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global Injectable Drug Delivery Devices (Value)
      • 5.2.1. Global Injectable Drug Delivery Devices by: Application (Value)
        • 5.2.1.1. Auto-immune diseases
        • 5.2.1.2. Hormonal Disorders
        • 5.2.1.3. Orphan Diseases
        • 5.2.1.4. Oncology
        • 5.2.1.5. Others
      • 5.2.2. Global Injectable Drug Delivery Devices by: Pattern (Value)
        • 5.2.2.1. Curative Care
        • 5.2.2.2. Immunization
        • 5.2.2.3. Other Usage Pattern
      • 5.2.3. Global Injectable Drug Delivery Devices by: Administration (Value)
        • 5.2.3.1. Circulatory/Musculoskeletal
        • 5.2.3.2. Organs
        • 5.2.3.3. Central Nervous System
      • 5.2.4. Global Injectable Drug Delivery Devices by: End Use (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Specialty Clinics
      • 5.2.5. Global Injectable Drug Delivery Devices by: Packaging (Value)
        • 5.2.5.1. Ampules
        • 5.2.5.2. Vials
        • 5.2.5.3. Cartridges
        • 5.2.5.4. Bottles
      • 5.2.6. Global Injectable Drug Delivery Devices Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Injectable Drug Delivery Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teva Pharmaceuticals Industries Ltd. (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Eli Lilly and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Gerresheimer (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Terumo Corporation (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Ypsomed (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sandoz (Novartis AG) (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. B. Braun Melsungen (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Baxter International, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Injectable Drug Delivery Devices Sale, by Application, Pattern, Administration, End Use, Packaging and Region (value) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global Injectable Drug Delivery Devices (Value)
      • 7.2.1. Global Injectable Drug Delivery Devices by: Application (Value)
        • 7.2.1.1. Auto-immune diseases
        • 7.2.1.2. Hormonal Disorders
        • 7.2.1.3. Orphan Diseases
        • 7.2.1.4. Oncology
        • 7.2.1.5. Others
      • 7.2.2. Global Injectable Drug Delivery Devices by: Pattern (Value)
        • 7.2.2.1. Curative Care
        • 7.2.2.2. Immunization
        • 7.2.2.3. Other Usage Pattern
      • 7.2.3. Global Injectable Drug Delivery Devices by: Administration (Value)
        • 7.2.3.1. Circulatory/Musculoskeletal
        • 7.2.3.2. Organs
        • 7.2.3.3. Central Nervous System
      • 7.2.4. Global Injectable Drug Delivery Devices by: End Use (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Specialty Clinics
      • 7.2.5. Global Injectable Drug Delivery Devices by: Packaging (Value)
        • 7.2.5.1. Ampules
        • 7.2.5.2. Vials
        • 7.2.5.3. Cartridges
        • 7.2.5.4. Bottles
      • 7.2.6. Global Injectable Drug Delivery Devices Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Injectable Drug Delivery Devices: by Application(USD Million)
  • Table 2. Injectable Drug Delivery Devices Auto-immune diseases , by Region USD Million (2019-2024)
  • Table 3. Injectable Drug Delivery Devices Hormonal Disorders , by Region USD Million (2019-2024)
  • Table 4. Injectable Drug Delivery Devices Orphan Diseases , by Region USD Million (2019-2024)
  • Table 5. Injectable Drug Delivery Devices Oncology , by Region USD Million (2019-2024)
  • Table 6. Injectable Drug Delivery Devices Others , by Region USD Million (2019-2024)
  • Table 7. Injectable Drug Delivery Devices: by Pattern(USD Million)
  • Table 8. Injectable Drug Delivery Devices Curative Care , by Region USD Million (2019-2024)
  • Table 9. Injectable Drug Delivery Devices Immunization , by Region USD Million (2019-2024)
  • Table 10. Injectable Drug Delivery Devices Other Usage Pattern , by Region USD Million (2019-2024)
  • Table 11. Injectable Drug Delivery Devices: by Administration(USD Million)
  • Table 12. Injectable Drug Delivery Devices Circulatory/Musculoskeletal , by Region USD Million (2019-2024)
  • Table 13. Injectable Drug Delivery Devices Organs , by Region USD Million (2019-2024)
  • Table 14. Injectable Drug Delivery Devices Central Nervous System , by Region USD Million (2019-2024)
  • Table 15. Injectable Drug Delivery Devices: by End Use(USD Million)
  • Table 16. Injectable Drug Delivery Devices Hospitals , by Region USD Million (2019-2024)
  • Table 17. Injectable Drug Delivery Devices Specialty Clinics , by Region USD Million (2019-2024)
  • Table 18. Injectable Drug Delivery Devices: by Packaging(USD Million)
  • Table 19. Injectable Drug Delivery Devices Ampules , by Region USD Million (2019-2024)
  • Table 20. Injectable Drug Delivery Devices Vials , by Region USD Million (2019-2024)
  • Table 21. Injectable Drug Delivery Devices Cartridges , by Region USD Million (2019-2024)
  • Table 22. Injectable Drug Delivery Devices Bottles , by Region USD Million (2019-2024)
  • Table 23. South America Injectable Drug Delivery Devices, by Country USD Million (2019-2024)
  • Table 24. South America Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 25. South America Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 26. South America Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 27. South America Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 28. South America Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 29. Brazil Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 30. Brazil Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 31. Brazil Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 32. Brazil Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 33. Brazil Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 34. Argentina Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 35. Argentina Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 36. Argentina Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 37. Argentina Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 38. Argentina Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 39. Rest of South America Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 40. Rest of South America Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 41. Rest of South America Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 42. Rest of South America Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 43. Rest of South America Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 44. Asia Pacific Injectable Drug Delivery Devices, by Country USD Million (2019-2024)
  • Table 45. Asia Pacific Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 46. Asia Pacific Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 47. Asia Pacific Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 48. Asia Pacific Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 49. Asia Pacific Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 50. China Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 51. China Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 52. China Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 53. China Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 54. China Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 55. Japan Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 56. Japan Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 57. Japan Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 58. Japan Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 59. Japan Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 60. India Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 61. India Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 62. India Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 63. India Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 64. India Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 65. South Korea Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 66. South Korea Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 67. South Korea Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 68. South Korea Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 69. South Korea Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 70. Taiwan Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 71. Taiwan Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 72. Taiwan Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 73. Taiwan Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 74. Taiwan Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 75. Australia Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 76. Australia Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 77. Australia Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 78. Australia Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 79. Australia Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 80. Rest of Asia-Pacific Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 81. Rest of Asia-Pacific Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 82. Rest of Asia-Pacific Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 83. Rest of Asia-Pacific Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 84. Rest of Asia-Pacific Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 85. Europe Injectable Drug Delivery Devices, by Country USD Million (2019-2024)
  • Table 86. Europe Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 87. Europe Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 88. Europe Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 89. Europe Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 90. Europe Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 91. Germany Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 92. Germany Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 93. Germany Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 94. Germany Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 95. Germany Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 96. France Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 97. France Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 98. France Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 99. France Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 100. France Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 101. Italy Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 102. Italy Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 103. Italy Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 104. Italy Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 105. Italy Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 106. United Kingdom Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 107. United Kingdom Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 108. United Kingdom Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 109. United Kingdom Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 110. United Kingdom Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 111. Netherlands Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 112. Netherlands Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 113. Netherlands Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 114. Netherlands Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 115. Netherlands Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 116. Rest of Europe Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 117. Rest of Europe Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 118. Rest of Europe Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 119. Rest of Europe Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 120. Rest of Europe Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 121. MEA Injectable Drug Delivery Devices, by Country USD Million (2019-2024)
  • Table 122. MEA Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 123. MEA Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 124. MEA Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 125. MEA Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 126. MEA Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 127. Middle East Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 128. Middle East Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 129. Middle East Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 130. Middle East Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 131. Middle East Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 132. Africa Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 133. Africa Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 134. Africa Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 135. Africa Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 136. Africa Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 137. North America Injectable Drug Delivery Devices, by Country USD Million (2019-2024)
  • Table 138. North America Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 139. North America Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 140. North America Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 141. North America Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 142. North America Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 143. United States Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 144. United States Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 145. United States Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 146. United States Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 147. United States Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 148. Canada Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 149. Canada Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 150. Canada Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 151. Canada Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 152. Canada Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 153. Mexico Injectable Drug Delivery Devices, by Application USD Million (2019-2024)
  • Table 154. Mexico Injectable Drug Delivery Devices, by Pattern USD Million (2019-2024)
  • Table 155. Mexico Injectable Drug Delivery Devices, by Administration USD Million (2019-2024)
  • Table 156. Mexico Injectable Drug Delivery Devices, by End Use USD Million (2019-2024)
  • Table 157. Mexico Injectable Drug Delivery Devices, by Packaging USD Million (2019-2024)
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Injectable Drug Delivery Devices: by Application(USD Million)
  • Table 169. Injectable Drug Delivery Devices Auto-immune diseases , by Region USD Million (2027-2032)
  • Table 170. Injectable Drug Delivery Devices Hormonal Disorders , by Region USD Million (2027-2032)
  • Table 171. Injectable Drug Delivery Devices Orphan Diseases , by Region USD Million (2027-2032)
  • Table 172. Injectable Drug Delivery Devices Oncology , by Region USD Million (2027-2032)
  • Table 173. Injectable Drug Delivery Devices Others , by Region USD Million (2027-2032)
  • Table 174. Injectable Drug Delivery Devices: by Pattern(USD Million)
  • Table 175. Injectable Drug Delivery Devices Curative Care , by Region USD Million (2027-2032)
  • Table 176. Injectable Drug Delivery Devices Immunization , by Region USD Million (2027-2032)
  • Table 177. Injectable Drug Delivery Devices Other Usage Pattern , by Region USD Million (2027-2032)
  • Table 178. Injectable Drug Delivery Devices: by Administration(USD Million)
  • Table 179. Injectable Drug Delivery Devices Circulatory/Musculoskeletal , by Region USD Million (2027-2032)
  • Table 180. Injectable Drug Delivery Devices Organs , by Region USD Million (2027-2032)
  • Table 181. Injectable Drug Delivery Devices Central Nervous System , by Region USD Million (2027-2032)
  • Table 182. Injectable Drug Delivery Devices: by End Use(USD Million)
  • Table 183. Injectable Drug Delivery Devices Hospitals , by Region USD Million (2027-2032)
  • Table 184. Injectable Drug Delivery Devices Specialty Clinics , by Region USD Million (2027-2032)
  • Table 185. Injectable Drug Delivery Devices: by Packaging(USD Million)
  • Table 186. Injectable Drug Delivery Devices Ampules , by Region USD Million (2027-2032)
  • Table 187. Injectable Drug Delivery Devices Vials , by Region USD Million (2027-2032)
  • Table 188. Injectable Drug Delivery Devices Cartridges , by Region USD Million (2027-2032)
  • Table 189. Injectable Drug Delivery Devices Bottles , by Region USD Million (2027-2032)
  • Table 190. South America Injectable Drug Delivery Devices, by Country USD Million (2027-2032)
  • Table 191. South America Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 192. South America Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 193. South America Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 194. South America Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 195. South America Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 196. Brazil Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 197. Brazil Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 198. Brazil Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 199. Brazil Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 200. Brazil Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 201. Argentina Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 202. Argentina Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 203. Argentina Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 204. Argentina Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 205. Argentina Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 206. Rest of South America Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 207. Rest of South America Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 208. Rest of South America Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 209. Rest of South America Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 210. Rest of South America Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 211. Asia Pacific Injectable Drug Delivery Devices, by Country USD Million (2027-2032)
  • Table 212. Asia Pacific Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 213. Asia Pacific Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 214. Asia Pacific Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 215. Asia Pacific Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 216. Asia Pacific Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 217. China Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 218. China Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 219. China Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 220. China Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 221. China Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 222. Japan Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 223. Japan Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 224. Japan Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 225. Japan Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 226. Japan Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 227. India Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 228. India Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 229. India Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 230. India Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 231. India Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 232. South Korea Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 233. South Korea Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 234. South Korea Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 235. South Korea Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 236. South Korea Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 237. Taiwan Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 238. Taiwan Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 239. Taiwan Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 240. Taiwan Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 241. Taiwan Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 242. Australia Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 243. Australia Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 244. Australia Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 245. Australia Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 246. Australia Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 247. Rest of Asia-Pacific Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 248. Rest of Asia-Pacific Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 249. Rest of Asia-Pacific Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 250. Rest of Asia-Pacific Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 251. Rest of Asia-Pacific Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 252. Europe Injectable Drug Delivery Devices, by Country USD Million (2027-2032)
  • Table 253. Europe Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 254. Europe Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 255. Europe Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 256. Europe Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 257. Europe Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 258. Germany Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 259. Germany Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 260. Germany Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 261. Germany Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 262. Germany Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 263. France Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 264. France Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 265. France Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 266. France Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 267. France Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 268. Italy Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 269. Italy Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 270. Italy Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 271. Italy Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 272. Italy Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 273. United Kingdom Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 274. United Kingdom Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 275. United Kingdom Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 276. United Kingdom Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 277. United Kingdom Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 278. Netherlands Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 279. Netherlands Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 280. Netherlands Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 281. Netherlands Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 282. Netherlands Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 283. Rest of Europe Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 284. Rest of Europe Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 285. Rest of Europe Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 286. Rest of Europe Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 287. Rest of Europe Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 288. MEA Injectable Drug Delivery Devices, by Country USD Million (2027-2032)
  • Table 289. MEA Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 290. MEA Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 291. MEA Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 292. MEA Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 293. MEA Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 294. Middle East Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 295. Middle East Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 296. Middle East Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 297. Middle East Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 298. Middle East Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 299. Africa Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 300. Africa Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 301. Africa Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 302. Africa Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 303. Africa Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 304. North America Injectable Drug Delivery Devices, by Country USD Million (2027-2032)
  • Table 305. North America Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 306. North America Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 307. North America Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 308. North America Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 309. North America Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 310. United States Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 311. United States Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 312. United States Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 313. United States Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 314. United States Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 315. Canada Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 316. Canada Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 317. Canada Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 318. Canada Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 319. Canada Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 320. Mexico Injectable Drug Delivery Devices, by Application USD Million (2027-2032)
  • Table 321. Mexico Injectable Drug Delivery Devices, by Pattern USD Million (2027-2032)
  • Table 322. Mexico Injectable Drug Delivery Devices, by Administration USD Million (2027-2032)
  • Table 323. Mexico Injectable Drug Delivery Devices, by End Use USD Million (2027-2032)
  • Table 324. Mexico Injectable Drug Delivery Devices, by Packaging USD Million (2027-2032)
  • Table 325. Research Programs/Design for This Report
  • Table 326. Key Data Information from Secondary Sources
  • Table 327. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Injectable Drug Delivery Devices: by Application USD Million (2019-2024)
  • Figure 5. Global Injectable Drug Delivery Devices: by Pattern USD Million (2019-2024)
  • Figure 6. Global Injectable Drug Delivery Devices: by Administration USD Million (2019-2024)
  • Figure 7. Global Injectable Drug Delivery Devices: by End Use USD Million (2019-2024)
  • Figure 8. Global Injectable Drug Delivery Devices: by Packaging USD Million (2019-2024)
  • Figure 9. South America Injectable Drug Delivery Devices Share (%), by Country
  • Figure 10. Asia Pacific Injectable Drug Delivery Devices Share (%), by Country
  • Figure 11. Europe Injectable Drug Delivery Devices Share (%), by Country
  • Figure 12. MEA Injectable Drug Delivery Devices Share (%), by Country
  • Figure 13. North America Injectable Drug Delivery Devices Share (%), by Country
  • Figure 14. Global Injectable Drug Delivery Devices share by Players 2024 (%)
  • Figure 15. Global Injectable Drug Delivery Devices share by Players (Top 3) 2024(%)
  • Figure 16. Global Injectable Drug Delivery Devices share by Players (Top 5) 2024(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 19. Becton, Dickinson and Company (United States) Revenue: by Geography 2024
  • Figure 20. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Pfizer Inc. (United States) Revenue: by Geography 2024
  • Figure 22. Teva Pharmaceuticals Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 23. Teva Pharmaceuticals Industries Ltd. (Israel) Revenue: by Geography 2024
  • Figure 24. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 25. Eli Lilly and Company (United States) Revenue: by Geography 2024
  • Figure 26. Gerresheimer (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Gerresheimer (Germany) Revenue: by Geography 2024
  • Figure 28. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 29. Terumo Corporation (Japan) Revenue: by Geography 2024
  • Figure 30. Ypsomed (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. Ypsomed (Switzerland) Revenue: by Geography 2024
  • Figure 32. Sandoz (Novartis AG) (Switzerland) Revenue, Net Income and Gross profit
  • Figure 33. Sandoz (Novartis AG) (Switzerland) Revenue: by Geography 2024
  • Figure 34. B. Braun Melsungen (Germany) Revenue, Net Income and Gross profit
  • Figure 35. B. Braun Melsungen (Germany) Revenue: by Geography 2024
  • Figure 36. Baxter International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Baxter International, Inc. (United States) Revenue: by Geography 2024
  • Figure 38. Global Injectable Drug Delivery Devices: by Application USD Million (2027-2032)
  • Figure 39. Global Injectable Drug Delivery Devices: by Pattern USD Million (2027-2032)
  • Figure 40. Global Injectable Drug Delivery Devices: by Administration USD Million (2027-2032)
  • Figure 41. Global Injectable Drug Delivery Devices: by End Use USD Million (2027-2032)
  • Figure 42. Global Injectable Drug Delivery Devices: by Packaging USD Million (2027-2032)
  • Figure 43. South America Injectable Drug Delivery Devices Share (%), by Country
  • Figure 44. Asia Pacific Injectable Drug Delivery Devices Share (%), by Country
  • Figure 45. Europe Injectable Drug Delivery Devices Share (%), by Country
  • Figure 46. MEA Injectable Drug Delivery Devices Share (%), by Country
  • Figure 47. North America Injectable Drug Delivery Devices Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Becton, Dickinson and Company (United States)
  • Pfizer Inc. (United States)
  • Teva Pharmaceuticals Industries Ltd. (Israel)
  • Eli Lilly and Company (United States)
  • Gerresheimer (Germany)
  • Terumo Corporation (Japan)
  • Ypsomed (Switzerland)
  • Sandoz (Novartis AG) (Switzerland)
  • B. Braun Melsungen (Germany)
  • Baxter International, Inc. (United States)
Additional players considered in the study are as follows:
Sulzer Ltd (Switzerland) , Schott AG (Germany) , SHL Medical (Switzerland)
Select User Access Type

Key Highlights of Report


Mar 2025 242 Pages 86 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Injectable Drug Delivery Devices Quantitative research analysis
Injectable Drug Delivery Devices Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Becton, Dickinson and Company (United States), Pfizer Inc. (United States), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (United States), Gerresheimer (Germany), Terumo Corporation (Japan), Ypsomed (Switzerland), Sandoz (Novartis AG) (Switzerland), B. Braun Melsungen (Germany) and Baxter International, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technical Progress in Healthcare Industry" is seen as one of major influencing trends for Injectable Drug Delivery Devices Market during projected period 2024-2032.
The Injectable Drug Delivery Devices market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Injectable Drug Delivery Devices Report?

Have a Query? Click Here

Other Related Reports

Respiratory Measurement Devices Comprehensive Study by Type (Oral High Frequency Oscillation (OHFO) Device, Intrapulmonary Percussive Ventilation (IPV) Device, Incentive Spirometry (I.S.) Device, Flu...
$ 3650
Meniscal Repair Comprehensive Study by Application (Rotator Cuff Tears, Bicep Tendon Tear, ACL/PCL Injury, Meniscus Tears), Repair Technique (Inside-Out, Outside-In, All-Inside, Root Tears) Players a...
$ 3500
Bioabsorbable Stents Comprehensive Study by Type (Bioresorbable Polymer-Based Stents (Poly-L-Lactic Acid, Polyglycolic Acid, Polycaprolactone), Bioresorbable Metallic Stents (Magnesium, Iron)), Appli...
$ 3650
Ultrasound Machines Comprehensive Study by Type (Stationary Ultrasound, Portable Ultrasound), Application (Radiology & General imaging, Obstetrics & Gynaecology, Cardiology, Urology, Others), Technol...
$ 3750
Trauma Products Comprehensive Study by Type (Internal (Plates, Screw, Nails, Pins, Staples), External Fixators (Circular, Hybrid)), Application (Motor Vehicle Collision Injuries, Sports Injuries, Fal...
$ 3650
Angiography System Comprehensive Study by Type (Head Part Angiography, Chest Angiography, Abdominal Angiography, Heart Angiography), Application (Radiology, Cardiology, Surgery), Technology (X-Ray, C...
$ 3450